CHILDREN'S HOSPITAL LOS ANGELES
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1901-04-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.chla.org
Clinical Trials
150
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (127 trials with phase data)• Click on a phase to view related trials
Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4
- Conditions
- Anesthesia; ReactionAnesthesia
- Interventions
- Drug: Randomization of Propofol or Dexmedetomidine
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 130
- Registration Number
- NCT07103616
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
Final Prototype Refinement of Adaptive Cell Phone Support
- Conditions
- Medication Adherence
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 35
- Registration Number
- NCT07084155
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
- Conditions
- Single-ventricleStenosis
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT07073612
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
Adaptive Cell Phone Support (ACPS)
- Conditions
- Medication Adherence
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 96
- Registration Number
- NCT07064824
- Locations
- 🇺🇸
Children Hospital Los Angeles, Los Angeles, California, United States
Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
- Conditions
- Congenital Heart Disease
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 40
- Registration Number
- NCT07023367
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 30
- Next
News
CHLA Pioneers Pig Heart Xenotransplantation Study for Critically Ill Infants
Children's Hospital Los Angeles researchers have become the first in the world to investigate using genetically engineered pig hearts as a "bridge" for infants awaiting heart transplants.
FDA Approves Trofinetide as First-Ever Treatment for Rett Syndrome, Opening New Era for Rare Genetic Disorder
The FDA has approved trofinetide (developed by ACADIA Pharmaceuticals) as the first-ever treatment for Rett syndrome, a rare genetic disorder primarily affecting females that causes severe developmental delays and neurological symptoms.
Children's Hospital Los Angeles Celebrates Milestone with 100th Retinal Gene Therapy Procedure
Children's Hospital Los Angeles (CHLA) celebrates administering its 100th retinal gene therapy, Luxturna, since 2018 for Leber congenital amaurosis (LCA).
MRE and TE Show Limited Accuracy in Detecting Advanced Liver Fibrosis in Pediatric MASLD Patients
A new study at Children's Hospital Los Angeles reveals that magnetic resonance elastography (MRE) and transient elastography (TE) demonstrate insufficient accuracy in detecting high-grade liver fibrosis in pediatric MASLD patients.